Trends in the Diagnostic Prevalence of Mental Disorders, 2012-2022.

IF 5.3 2区 材料科学 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY ACS Applied Nano Materials Pub Date : 2024-05-31 DOI:10.3238/arztebl.m2024.0052
Julia Thom, Benjamin Jonas, Lukas Reitzle, Elvira Mauz, Heike Hölling, Mandy Schulz
{"title":"Trends in the Diagnostic Prevalence of Mental Disorders, 2012-2022.","authors":"Julia Thom, Benjamin Jonas, Lukas Reitzle, Elvira Mauz, Heike Hölling, Mandy Schulz","doi":"10.3238/arztebl.m2024.0052","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Evaluations by the statutory health insurance carriers in Germany have revealed a rising prevalence of diagnoses of mental disorders, at varying levels and to varying extents. For mental health surveillance purposes, we analyzed prevalence trends across health insurance carriers, before and during the COVID-19 pandemic and stratified by diagnosis group, sex and age.</p><p><strong>Methods: </strong>Nationwide outpatient claims data of all statutorily insured individuals for the years 2012-2022 (Nmin = 68.7 million people, Nmax = 73.7 million people) were used to determine the diagnostic prevalence of mental disorders (ICD-10 F00-F99 and five selected diagnosis groups), with stratification by sex and age. Changes over time in the spectrum of all documented mental disorders are described.</p><p><strong>Results: </strong>Over the period 2012-2022, the percentage of people with outpatient diagnoses of mental disorders rose from 33.4% to 37.9% (a relative increase of 13.4%). In the selected diagnosis groups, the trends ranged from -11.6% to +115.8% and were generally steady over time, though stronger or stagnating trends were seen in some groups from 2020 onward. Diagnostic prevalence rose to a greater extent in male (+18.3%) than in female individuals (+10.8%) over the period 2012-2022. The greatest increases (> +15%) were seen among 11- to 17-yearolds and in 60- to 84-year-olds. The composition of the diagnosis spectrum was more stable in adults than in children and adolescents.</p><p><strong>Conclusion: </strong>Trends in diagnostic prevalence differ across mental disorders and population subgroups and have changed in some diagnosis groups since the COVID-19 pandemic. Contextualizing research is needed for a better understanding of these developments.</p>","PeriodicalId":6,"journal":{"name":"ACS Applied Nano Materials","volume":null,"pages":null},"PeriodicalIF":5.3000,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539879/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Nano Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3238/arztebl.m2024.0052","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Evaluations by the statutory health insurance carriers in Germany have revealed a rising prevalence of diagnoses of mental disorders, at varying levels and to varying extents. For mental health surveillance purposes, we analyzed prevalence trends across health insurance carriers, before and during the COVID-19 pandemic and stratified by diagnosis group, sex and age.

Methods: Nationwide outpatient claims data of all statutorily insured individuals for the years 2012-2022 (Nmin = 68.7 million people, Nmax = 73.7 million people) were used to determine the diagnostic prevalence of mental disorders (ICD-10 F00-F99 and five selected diagnosis groups), with stratification by sex and age. Changes over time in the spectrum of all documented mental disorders are described.

Results: Over the period 2012-2022, the percentage of people with outpatient diagnoses of mental disorders rose from 33.4% to 37.9% (a relative increase of 13.4%). In the selected diagnosis groups, the trends ranged from -11.6% to +115.8% and were generally steady over time, though stronger or stagnating trends were seen in some groups from 2020 onward. Diagnostic prevalence rose to a greater extent in male (+18.3%) than in female individuals (+10.8%) over the period 2012-2022. The greatest increases (> +15%) were seen among 11- to 17-yearolds and in 60- to 84-year-olds. The composition of the diagnosis spectrum was more stable in adults than in children and adolescents.

Conclusion: Trends in diagnostic prevalence differ across mental disorders and population subgroups and have changed in some diagnosis groups since the COVID-19 pandemic. Contextualizing research is needed for a better understanding of these developments.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2012-2022年精神障碍诊断流行趋势--利用全国门诊病人索赔数据进行精神健康监测》(Trends in the Diagnostic Prevalence of Mental Disorders, 2012-2022-Using Nationalwide Outpatient Claims Data for Mental Health Surveillance)。
背景:德国法定医疗保险承保机构的评估显示,精神障碍诊断的患病率在不同程度和不同范围内不断上升。为了监测精神健康状况,我们分析了 COVID-19 大流行之前和期间各医疗保险公司的患病率趋势,并按诊断类别、性别和年龄进行了分层:我们使用了 2012-2022 年所有法定投保人的全国门诊理赔数据(Nmin = 6870 万人,Nmax = 7370 万人)来确定精神障碍的诊断流行率(ICD-10 F00-F99 和五个选定的诊断组),并按性别和年龄进行了分层。结果显示,2012-2022 年间,全球精神障碍的患病率为 1.5%,而 2012 年为 1.5%:结果:2012-2022 年间,门诊诊断为精神障碍的患者比例从 33.4% 上升至 37.9%(相对增长 13.4%)。在选定的诊断组别中,趋势从-11.6%到+115.8%不等,并且随着时间的推移基本保持稳定,但从2020年起,某些组别的趋势更强或停滞不前。在 2012-2022 年期间,男性诊断率的上升幅度(+18.3%)大于女性(+10.8%)。11-17岁和60-84岁人群的增幅最大(> +15%)。与儿童和青少年相比,成人诊断范围的构成更为稳定:结论:自 COVID-19 大流行以来,不同精神障碍和人群亚群的诊断流行趋势各不相同,某些诊断组别也发生了变化。为了更好地了解这些发展,需要进行背景研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.30
自引率
3.40%
发文量
1601
期刊介绍: ACS Applied Nano Materials is an interdisciplinary journal publishing original research covering all aspects of engineering, chemistry, physics and biology relevant to applications of nanomaterials. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrate knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important applications of nanomaterials.
期刊最新文献
Pretreatment With Unfractionated Heparin in ST-Elevation Myocardial Infarction—a Propensity Score Matching Analysis. The Diagnosis and Treatment of Hypertrophic Cardiomyopathy. Clinical Practice Guideline: Condylar Hyperplasia of the Mandible—Diagnosis and Treatment. The Diagnosis and Treatment of Neuropathic Pain. Statement of Retraction.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1